ArticleDermatology online journal2025
Rapidly progressing Kaposi sarcoma in a human immunodeficiency virus-negative patient.
Article in Dermatology online journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kaposi sarcoma (KS) is a vascular tumor caused by human herpesvirus-8 (HHV-8), most often associated with human immunodeficiency virus (HIV)-positive individuals. However, KS can also occur in HIV-negative patients, though less commonly. We report a rare case of classic KS in an HIV-negative man with no history of male-to-male sexual activity, who experienced rapid progression to stage IV disease within 3 months. To our knowledge, this is the first documented case of classic KS in Vietnam, highlighting the potential for aggressive KS presentations in immunocompetent Asian individuals. This case underscores the importance of considering KS in the differential diagnosis of rapidly advancing skin lesions, even in patients without traditional risk factors, to ensure timely diagnosis and appropriate management.
Indexed as
Identifiers
41725475What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.